astrazeneca defends covid vaccine trial results amid questions
Published 3 years ago • 12K plays • Length 3:51Download video MP4
Download video MP3
Similar videos
-
3:10
astrazeneca revises covid vaccine data with lower efficacy rate after accuracy questions
-
4:48
astrazeneca executive explains positive covid-19 vaccine results
-
4:57
oxford professor on the timeline of the astrazeneca covid-19 vaccine
-
3:17
oxford/astrazeneca covid-19 vaccine can be up to 90% effective
-
2:27
astrazeneca vaccine found to be 79% effective in u.s. trial
-
17:57
how biontech used cancer research to create its covid vaccine
-
10:24
key researcher in astrazeneca's oxford vaccine breaks down trials data
-
6:18
blood clots, fda approval, and the astrazeneca covid vaccine
-
3:31
astrazeneca announces its vaccine efficacy rate, cdc group meets to discuss vaccine distribution
-
3:14
astrazeneca ceo addresses coronavirus trial pause
-
7:47
who: delay in astrazeneca coronavirus vaccine trial is a 'wake up call'
-
6:20
who on oxford-astrazeneca coronavirus vaccine data: it is good news
-
1:58
oxford-astrazeneca vaccine shows positive immune response in early study
-
8:14
astrazeneca down after report that covid-19 vaccine is put on hold
-
5:30
oxford: millions of covid-19 vaccine doses ready by year's end
-
6:01
why doctors are concerned about the oxford/astrazeneca vaccine
-
2:40
astrazeneca ceo awaits diagnosis on covid-19 trial participant who developed neurological condition
-
1:30
questions over astrazeneca's covid-19 vaccine data
-
3:35
astrazeneca says it's likely to run fresh global vaccine trial
-
2:25
oxford-astrazeneca covid-19 vaccine approved by u.k. regulator
-
4:41
there is a 'shroud of fog' developing around astrazeneca
-
0:33
astrazeneca surges after hhs provides $500 million for covid-19 antibody treatment development